Skip to main content

Holocene Advisors, LP

Position in BIIB — Biogen Inc.

CIK 1700574 New York, NY

Position in BIIB

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$878,700
+$41,162 QoQ
Shares Held
4,793
-19.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
7 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in BIIB Over Time

Shares Held

Position Value (USD)

Derivatives in BIIB

reported options exposure · as of Jun 30, 2021
CallValue
$45,880,775
CallShares
132,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

Holocene Advisors, LP holds $1,499,965,087 across 7 Drug Manufacturers - General names. BIIB ranks #7 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 BIIB
Biogen Inc.
This page
4,793 $878,700

All Filings in BIIB

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $878,700 4,793
2025-09-30 $837,538 5,979
2023-06-30 $1,079,866 3,791
2023-03-31 $53,967,013 194,105
2021-06-30 $45,880,775 132,500
2021-06-30 $474,389 1,370
2020-06-30 $92,304,750 345,000
2020-03-31 $71,966,642 227,469